ICYMI: Subcutaneous #Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient access, according to experts. @lungoncdoc @BalazsHalmosMD @EinsteinMed @MDAndersonNews #lcsm #MedTwitter 

Read more:
#Opdivo #lcsm #MedTwitter